Skip to content

Clinical trials

Phase 3 Major Depressive Disorder trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Phase 3 Country / region: Italy Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20101
20111
20121
20163
20171
20222
20243
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting6
Terminated3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
H. Lundbeck A/S4
Janssen Research & Development, LLC4
Eli Lilly and Company2
Neurocrine Biosciences2
AstraZeneca1
Aziende Chimiche Riunite Angelini Francesco S.p.A1
Dr. Inge Winter1
MGGM LLC1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Università Vita-Salute San Raffaele1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder18
Depressive Disorder, Treatment-Resistant3
Anhedonia1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.